Clinical Trial Update: Efficacy of Cetuximab in Combination With Irinotecan and 5- FU/FA in Treatment of Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating cetuximab with irinotecan and 5-FU/folinic acid in metastatic gastric cancer. The trial has completed and reported efficacy findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Junction Adenocarcinoma
• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: Johannes Gutenberg University Mainz | Conditions: Adenocarcinoma of Stomach or Esophagogastric Junction | Phase 2 | Status: COMPLETED